 SALT LAKE CITY , March 14, 2022 PRNewswire -- Co-Diagnostics, Inc. Nasdaq: CODX, a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today it will release its fourth quarter and full year 2021 results on Thursday, March 24, 2022, after the market close. The Company will also host a conference call and webcast on the same day at 4:30 p.m. 